Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | SLC9A1 | P19634 | 7/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | THPO | P40225 | 1/20 | 0.50 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.46 |
| ▸ | MGAM | O43451 | 2/20 | 0.44 |
| ▸ | AMY1A | P0DUB6 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30586926 | 1.00 | RAB9A (0.53) | RAB9ANPC1SLC9A1POLBMAPK1 | |
| SCHEMBL7100624 | 0.79 | RAB9A (0.53) | RAB9ANPC1SLC9A1POLBMAPK1 | |
| SCHEMBL6008529 | 0.79 | RAB9A (0.53) | RAB9ANPC1SLC9A1POLBMAPK1 | |
| SCHEMBL7227104 | 0.79 | SLC9A1 (0.55) | RAB9ANPC1SLC9A1POLBMAPK1 | |
| SCHEMBL1568148 | 0.79 | RAB9A (0.53) | RAB9ANPC1SLC9A1POLBMAPK1 | |
| SCHEMBL24254311 | 0.76 | RAB9A (0.58) | RAB9ANPC1SLC9A1POLBMAPK1 | |
| SCHEMBL19111807 | 0.76 | RAB9A (0.58) | RAB9ANPC1SLC9A1POLBMAPK1 | |
| SCHEMBL7659389 | 0.76 | RAB9A (0.58) | RAB9ANPC1SLC9A1POLBMAPK1 | |
| SCHEMBL14489533 | 0.76 | RAB9A (0.58) | RAB9ANPC1SLC9A1POLBMAPK1 | |
| SCHEMBL28979849 | 0.76 | RAB9A (0.54) | RAB9ANPC1SLC9A1POLBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 506 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118909535-B | Yellowing-resistant aging-resistant polyurethane resin coating material and preparation method thereof | 福建兴宇树脂有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-118909535-A | Yellowing-resistant aging-resistant polyurethane resin coating material and preparation method thereof | 福建兴宇树脂有限公司 | 2024-11-08 | — | — | CN | claimed |
| CN-113045574-B | Process for preparing diazapine derivatives and intermediates therefor | 浙江京新药业股份有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-117448064-A | Conductive lubricant | 甘肃海亮新能源材料有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-116103647-A | Novel blackening liquid medicine and preparation method thereof and conductive film blackening method | 江苏软讯科技有限公司 | 2023-05-12 | — | — | CN | claimed |
| CN-114057724-A | BTK inhibitor | 鲁南制药集团股份有限公司 | 2022-02-18 | — | — | CN | claimed |
| CN-113045574-A | Process for preparing diazepine derivative and intermediates thereof | 浙江京新药业股份有限公司 | 2021-06-29 | — | — | CN | claimed |
| CN-110937987-A | Synthetic route of compound and application of compound in field of preparation of antidiabetic drugs | 深圳市灵兰生物医药科技有限公司 | 2020-03-31 | — | — | CN | claimed |
| EP-2141148-B1 | INDOLE DERIVATIVE HAVING CPLA2 INHIBITORY ACTIVITY, USE OF THE SAME AND METHOD FOR PRODUCING THE SAME | DAIICHI SANKYO CO LTD (JP) | 2013-07-03 | — | — | EP | claimed |
| US-8293781-B2 | Indole derivatives having cPLA2 inhibiting activity and applications and production methods of the same | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-10-23 | — | — | US | claimed |
| US-20070224919-A1 | Iodate-containing chemical-mechanical polishing compositions and methods | CABOT MICROELECTRONICS CORPORATION (US) | 2007-09-27 | — | — | US | claimed |
| CN-1125069-C | Preparation of alkylthio- and/or arylthio-substd. diketo-diaryl-pyrrolopyrroles | CIBA SPACIALTY CHEMICALS HOLDI (CH) | 2003-10-22 | — | — | CN | claimed |
| US-20030069447-A1 | Acetal hydroxylamine compounds | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 2003-04-10 | — | — | US | claimed |
| US-20030023023-A1 | Hydrolytically degradable polymers and hydrogels made therefrom | SHEARWATER CORPORATION | 2003-01-30 | — | — | US | claimed |
| EP-1255727-A1 | ACETAL HYDROXYLAMINE COMPOUNDS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 2002-11-13 | — | — | EP | claimed |
| US-6348558-B1 | OLIGOMERS COMPRISING ALKYLENE OXIDE MONOMERS AND CARBONATE LINKAGES; POLYCARBONATEETHER COPOLYMERS; DRUG DELIVERY; CONJUGATED TO PEPTIDES OR PROTEINS FOR REDUCED IMMUNOGENICITY; STABILITY | SHEARWATER CORPORATION | 2002-02-19 | — | — | US | claimed |
| WO-2001060785-A1 | ACETAL HYDROXYLAMINE COMPOUNDS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 2001-08-23 | — | — | WO | claimed |
| CN-1297450-A | Preparation of alkylthio- and/or arylthio-substd. diketo-diaryl-pyrrolopyrroles | CIBA SC HOLDING AG (CH) | 2001-05-30 | — | — | CN | claimed |
| US-6187905-B1 | PEPTIDE COMPOUND WHICH INHIBITS VIRAL PROTEINASES; VIRICIDES FOR HEPATITIS C, HEPATITIS G, AND HUMAN GB VIRUSES | HOFFMANN-LA ROCHE INC. | 2001-02-13 | — | — | US | claimed |
| US-6106599-A | Inks | XEROX CORPORATION (US) | 2000-08-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069447-A1 | Acetal hydroxylamine compounds | HRH3, H1-0, HNMT | RAB9A 2392/4885NPC1 2802/4885SLC9A1 770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.